CPT2 and cancer: Further, novel drug delivery systems, such as nanoparticles, polymer micelles, and ligand-modified carriers can improve the targeted delivery of CPT1 inhibitors to tumors (e.g., through folic acid or transferrin receptors overexpressed on cancer cells) [153].